Stock Track | Phibro Animal Health Soars 10.98% in Pre-Market on Strong Q2 Earnings and Raised Guidance

Stock Track

Feb 05

Phibro Animal Health's stock experienced a significant surge of 10.98% during pre-market trading on Thursday, following the release of its quarterly financial results.

The sharp increase came after the company reported fiscal second-quarter adjusted earnings and sales that exceeded analyst expectations. Additionally, Phibro Animal Health raised its full-year fiscal 2026 outlook, providing investors with increased confidence in the company's future performance.

According to the earnings report released late Wednesday, the company posted adjusted earnings of $0.87 per diluted share for the quarter ended December 31, significantly higher than the $0.55 reported a year earlier and beating the FactSet consensus estimate of $0.67. Revenue also showed strong growth, reaching $373.9 million compared to $309.3 million in the same period last year and surpassing the $355.6 million expected by analysts.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1162859994"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162859994\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162859994?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 21:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162859994","market":"us","top_or_hot":-1,"title":"Stock Track | Phibro Animal Health Soars 10.98% in Pre-Market on Strong Q2 Earnings and Raised Guidance","media":"Stock Track","content":"<p>Phibro Animal Health's stock experienced a significant surge of 10.98% during pre-market trading on Thursday, following the release of its quarterly financial results.</p><p>The sharp increase came after the company reported fiscal second-quarter adjusted earnings and sales that exceeded analyst expectations. Additionally, Phibro Animal Health raised its full-year fiscal 2026 outlook, providing investors with increased confidence in the company's future performance.</p><p>According to the earnings report released late Wednesday, the company posted adjusted earnings of $0.87 per diluted share for the quarter ended December 31, significantly higher than the $0.55 reported a year earlier and beating the FactSet consensus estimate of $0.67. Revenue also showed strong growth, reaching $373.9 million compared to $309.3 million in the same period last year and surpassing the $355.6 million expected by analysts.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Phibro Animal Health Soars 10.98% in Pre-Market on Strong Q2 Earnings and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Phibro Animal Health Soars 10.98% in Pre-Market on Strong Q2 Earnings and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-05 21:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Phibro Animal Health's stock experienced a significant surge of 10.98% during pre-market trading on Thursday, following the release of its quarterly financial results.</p><p>The sharp increase came after the company reported fiscal second-quarter adjusted earnings and sales that exceeded analyst expectations. Additionally, Phibro Animal Health raised its full-year fiscal 2026 outlook, providing investors with increased confidence in the company's future performance.</p><p>According to the earnings report released late Wednesday, the company posted adjusted earnings of $0.87 per diluted share for the quarter ended December 31, significantly higher than the $0.55 reported a year earlier and beating the FactSet consensus estimate of $0.67. Revenue also showed strong growth, reaching $373.9 million compared to $309.3 million in the same period last year and surpassing the $355.6 million expected by analysts.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PAHC","symbol_name":"Phibro Animal Health Corporation","start_time":0,"source_url":"","article_id":"1162859994","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162859994","pubTimestamp":1770296802,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Phibro Animal Health's stock experienced a significant surge of 10.98% during pre-market trading on Thursday, following the release of its quarterly financial results.The sharp increase came after...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PAHC":"Phibro Animal Health Corporation"},"translate_title":"个股追踪|Phibro Animal Health盘前飙升10.98%，因Q2盈利强劲并上调指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PAHC":1},"content_text":"Phibro Animal Health's stock experienced a significant surge of 10.98% during pre-market trading on Thursday, following the release of its quarterly financial results.The sharp increase came after the company reported fiscal second-quarter adjusted earnings and sales that exceeded analyst expectations. Additionally, Phibro Animal Health raised its full-year fiscal 2026 outlook, providing investors with increased confidence in the company's future performance.According to the earnings report released late Wednesday, the company posted adjusted earnings of $0.87 per diluted share for the quarter ended December 31, significantly higher than the $0.55 reported a year earlier and beating the FactSet consensus estimate of $0.67. Revenue also showed strong growth, reaching $373.9 million compared to $309.3 million in the same period last year and surpassing the $355.6 million expected by analysts.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}